Both in Pharmaceuticals
Nexentis Technologies vs Decoy Therapeutics
Over the past year NXTS returned −91.9% and DCOY returned −86.9%; their daily moves had a correlation of 0.87.
NXTS −91.9% DCOY −86.9%Growth of $1, one year, split-adjusted
| Metric | NXTS | DCOY |
|---|---|---|
| Price | $0.5853 | $1.07 |
| Market cap | $850.6K | $701.0K |
| Today | −7.24% | −13.01% |
| 1 month | −59.1% | −42.3% |
| 6 months | — | −81.9% |
| Year to date | — | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −1042.8% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $8.5M | $8.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 121.8% |
| Short % of float | 2.5% | 16.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).